It requires the integration of a molecular pathology driven approach throughout the therapeutic development cycle.
GPOL has four divisions to facilitate this important integration.
Purpose-built molecular profiling laboratory specialising in sequencing and custom assay design.
Focuses on in vitro development of therapeutic strategies through the understanding of underlying tumour biology.
Assesses candidate novel therapeutic vulnerabilities to build a preclinical platform of evidence to support testing in the clinic.
Implementation of preclinical evidence into clinical trials.
We are looking for highly motivated and innovative individuals to join our team of pioneering researchers.Join The Team